Method for preparing chiral 1, 2, 3, 4-tetrahydro-1-naphthoic acid
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 国药集团工业有限公司
- Publication Date
- 2013-01-02
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of medicinal chemistry, in particular to a method for preparing chiral 1,2,3,4-tetrahydro-1-naphthoic acid. Background technique
[0002] Palonosetron hydrochloride (Palonosetron), trade name Aloxi (Aloxi), belongs to 5-HT 3 Receptor antagonists for the prevention of acute and delayed emesis caused by moderately or highly emetogenic chemotherapy regimens. Developed by Swiss company Helsinn, it was first launched in the United States in September 2003. In 2006, the global sales of the drug reached 250 million US dollars. The drug is characterized by low dose, long action time, and little toxic and side effects, and occupies an important position in antiemetic drugs.
[0003] Document US5510486 reports that the key intermediate of palonosetron hydrochloride (S)-1,2,3,4-tetrahydro-1-naphthoic acid is synthesized by a resolution method, using quinine as a resolution agent to resolve and eliminate Rotated 1,2,3,4-tetr...